Immunotherapeutic options for management of relapsed or refractory B-cell acute lymphoblastic leukemia: how to select newly approved agents?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapeutic options for management of relapsed or refractory B-cell acute lymphoblastic leukemia: how to select newly approved agents?

Published:2019-07-18 Issue:1 Volume:61 Page:7-17
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Dhakal Prajwal¹²^ORCID,Kaur Jasleen³,Gundabolu Krishna¹²,Bhatt Vijaya Raj¹²

Affiliation:

1. Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA;

2. Fred and Pamela Buffett Cancer Center, Omaha, NE, USA;

3. Department of Internal Medicine, Hurley Medical Center/Michigan State University, Flint, MI, USA

Funder

National Institute of General Medical Sciences

National Cancer Institute

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2019.1641802

Reference84 articles.

1. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

2. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993

3. Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia

4. Acute lymphoblastic leukemia: a comprehensive review and 2017 update

5. Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune therapies of B-cell acute lymphoblastic leukaemia in children and adults;Critical Reviews in Oncology/Hematology;2024-04

2. Switching from salvage chemotherapy to immunotherapy in adult B-cell acute lymphoblastic leukemia;Blood Reviews;2023-05

3. Clinical use of CAR T-cells in treating acute lymphoblastic leukemia;Transfusion and Apheresis Science;2023-04

4. Experts’ consensus on the definition and management of high risk multiple myeloma;Frontiers in Oncology;2023-01-23

5. Immunotherapy and Allogeneic Bone Marrow Transplantation in B Acute Lymphoblastic Leukemia: How to Sequence?;Clinical Hematology International;2022-05-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3